Snapshot · Russell 3000 · generated 2026-11-11 21:49 UTC

BCRX — BioCryst Pharmaceuticals, Inc.

UNDERVALUED (MOS Model unreliable) · Quality 55/100

Value Score 30 days ago: 43.3 → today 45.9

BCRX - BioCryst Pharmaceuticals, Inc.
Data generated 2026-11-11 21:49 UTC (nightly scan, universe: Russell 3000).
Price: 7.65 USD
Intrinsic value: 25.02 USD
Margin of safety: Model unreliable
Implied growth (reverse DCF): -7.8% (model assumes +10.0%)
Valuation: UNDERVALUED
Value Score: 45.9
Quality: 55/100
Moat score: 77.2 (erosion: none)
UNDERVALUED (MOS Model unreliable) - Quality 55/100
Source: StocksDeepDive - https://stocksdeepdive.com/s/BCRX
Factual information and general commentary only. StocksDeepDive publishes data, model outputs and described calculations from stated inputs. Nothing on this site takes your personal objectives, financial situation or needs into account, and nothing here is financial product advice or a recommendation to buy, hold or sell any security. Model outputs depend entirely on their stated inputs and assumptions. Consider seeking advice from a licensed adviser before acting. Data via Yahoo Finance, Google Trends, StockTwits and NewsAPI; figures may be delayed or revised.

Price

7.65

Intrinsic value

25.02

Margin of safety

Model unreliable

Implied growth (reverse DCF)

-7.8%

model assumes +10.0%

Value Score

45.9

Quality

Psychology

24.8

Discovery

12.5

price/volume attention only

Moat score

77.2

erosion: none

Value Score: top 9% of Russell 3000 · Quality: top 48%

Open the interactive Deep Dive for BCRX →

Use this data programmatically

This page's numbers are also available as JSON at /api/v1/deep-dive/BCRX - see the API docs for the full read-only surface, including an MCP server for AI assistants.

Common questions

Is BCRX undervalued?

As of 2026-11-11, BCRX trades at 7.65 against a computed intrinsic value of 25.02 (+69.4% margin of safety) - StocksDeepDive's valuation label for this is UNDERVALUED. This is a described calculation from public data, not a recommendation.

What is BioCryst Pharmaceuticals, Inc.'s Value Score?

BioCryst Pharmaceuticals, Inc.'s Value Score is 45.9 as of 2026-11-11 - it combines value, quality, crowd psychology and market attention into one number.